Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
Published in Critical Care
Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
Bedside POCUS during ward emergencies is associated with improved diagnosis and outcome: an observational, prospective, ...
...Published in Critical Care
BackgroundRapid response teams are intended to improve early diagnosis and intervention in ward patients who develop acute respiratory or circulatory failure. A management protocol including the use of a handheld ultrasound device for immediate point-of-care ultrasound (POCUS) examination at the bedside may improve team performance. The main object...
Diaphragm echodensity in mechanically ventilated patients: a description of technique and outcomes
Published in Critical Care
Background Acute increases in muscle sonographic echodensity reflect muscle injury. Diaphragm echodensity has not been measured in mechanically ventilated patients. We undertook to develop a technique to characterize changes in diaphragm echodensity during mechanical ventilation and to assess whether these changes are correlated with prolonged mech...
Palliative, palliative or palliative?
Published in Critical Care
Bedside voluntary and evoked forces evaluation in intensive care unit patients: a narrative review
Published in Critical Care
Around one third of intensive care unit (ICU) patients will develop severe neuromuscular alterations, known as intensive care unit-acquired weakness (ICUAW), during their stay. The diagnosis of ICUAW is difficult and often delayed as a result of sedation or delirium. Indeed, the clinical evaluation of both Medical Research Council score and maximal...
Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS
Published in Critical Care
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from...
...Published in Critical Care
Background The randomized, double-blind, phase 3 ASPECT-NP trial evaluated the efficacy of 3 g of ceftolozane/tazobactam (C/T) versus 1 g of meropenem infused every 8 h for 8 to 14 days for treatment of adults with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP). We assessed the probability of target...
Oral health care for the critically ill: a narrative review
Published in Critical Care
Background The link between oral bacteria and respiratory infections is well documented. Dental plaque has the potential to be colonized by respiratory pathogens and this, together with microaspiration of oral bacteria, can lead to pneumonia particularly in the elderly and critically ill. The provision of adequate oral care is therefore essential f...
The knowns and unknowns of perfusion disturbances in COVID-19 pneumonia
Published in Critical Care
The impact of wearable continuous vital sign monitoring on deterioration detection and clinical outcomes in hospitalised...
Published in Critical Care
Background Timely recognition of the deteriorating inpatient remains challenging. Wearable monitoring systems (WMS) may augment current monitoring practices. However, there are many barriers to implementation in the hospital environment, and evidence describing the clinical impact of WMS on deterioration detection and patient outcome remains unclea...
